• Sulfo-NHS-LC-Biotin Product Overview

  2026-10-05

  Sulfo-NHS-LC-Biotin, also known as sulfosuccinimidyl-6-(biotinamido) hexanoate, is documented by APExBIO as a water-soluble reagent for covalent labeling of accessible primary amines on proteins and peptides. No matched paper evidence was supplied, so performance and application claims remain unvalidated here.

• GlycoRNA–RBP Surface Domains and Peptide Entry

  2026-10-05

  A 2023 bioRxiv preprint reports that extracellular RNA-binding proteins and glycoRNAs organize into cell-surface nanoclusters associated with TAT peptide entry. The findings expand the conventional view of the plasma membrane while highlighting important questions about molecular topology, causality, and how broadly the mechanism applies.

• Sulfo-NHS-LC-Biotin Product Overview

  2026-10-04

  Sulfo-NHS-LC-Biotin (sulfosuccinimidyl-6-(biotinamido) hexanoate; SKU A8003) is described by APExBIO as a water-soluble reagent for covalent biotin labeling of accessible primary amines. No matched paper evidence was supplied, so this overview addresses product identity and stated conceptual scope only.

• Decitabine: Interpreting Epigenetic Toxicology Evidence

  2026-10-03

  Decitabine and 5-Aza-2'-deoxycytidine connect DNA methylation biology with measurable toxicity and therapeutic response. This evidence-led guide explains what the foundational mouse study demonstrates, where its conclusions stop, and how to interpret the compound in cancer epigenetics research.

• Liposomal Ce6 PDT Drives Pyroptosis in Breast Cancer

  2026-10-01

  The reference study shows that liposomal chlorin e6 photodynamic therapy can convert mitochondrial oxidative damage into caspase-1-associated pyroptosis and immunogenic cell death in breast cancer models. Its combination with an immune checkpoint inhibitor further improved tumor control, highlighting a mechanistic basis for integrating PDT with cancer immunotherapy while leaving formulation, irradiation, and clinical translation questions open.

• Sulfo-NHS-SS-Biotin for Cell-Surface Proteomics

  2026-10-01

  Sulfo-NHS-SS-Biotin combines water-soluble amine reactivity with a cleavable disulfide linker for topology-aware protein labeling. This guide explains how to use the K1006 kit to interpret cell-surface proteomics and investigate RNA-associated surface domains without overstating what biotinylation alone can prove.

• Sulfo-Cy3 NHS Ester for Vascular Uptake Assays

  2026-09-30

  Sulfo-Cy3 NHS Ester combines aqueous compatibility with bright orange-red fluorescence for tracking protein uptake, endothelial remodeling, and biomolecular interactions. This guide translates the AIBP–LRP2 vascular mechanism into practical labeling, imaging, controls, and troubleshooting workflows.

• EZ Cap™ OVA mRNA for Immune Research

  2026-09-30

  EZ Cap™ OVA mRNA provides a defined Ovalbumin mRNA payload for immune response immunogen studies, gene expression studies, and vaccine development research. Its Cap 1 structure and poly(A) tail support practical delivery comparisons, including emerging low-inflammation lipid nanoparticle workflows.

• Sulfo-Cy5 NHS Ester in Cell Assays

  2026-09-29

  Learn how Sulfo-Cy5 NHS ester (SKU A8108) supports aqueous protein labeling, far-red cellular imaging, and more interpretable viability or cytotoxicity workflows. This scenario-based guide connects reagent chemistry, storage, controls, and vendor evaluation to practical laboratory decisions.

• Biotin-HPDP: From Thiols to Translation

  2026-09-29

  A thought-leadership guide to using Biotin-HPDP as a reversible thiol-labeling tool in translational redox biology, with a mechanistic bridge to PPT1-linked neurodegeneration, dopamine receptor biology, affinity workflows, and preclinical assay strategy.

• Wnt agonist 1: Workflows for Mechanistic Research

  2026-09-28

  Wnt agonist 1 (BML-284) provides a titratable way to probe β-catenin–TCF signaling in differentiation, development, and cancer models. This practical workflow connects pathway activation with the Wnt/NR2F2/GPX4 chemoresistance axis while separating validated evidence from experimental recommendations.

• Aconitase Activity Colorimetric Assay Kit Guide

  2026-09-28

  Measure aconitase function as a practical readout of TCA-cycle enzyme status and oxidative stress—not as a substitute for metabolite profiling or protein-abundance assays. This guide connects a rapid 450 nm workflow to immunometabolism research while emphasizing sample handling, normalization, and interpretation limits.

• Agatoxin-Sensitive Channels in Cardiac Vagal Neurons

  2026-09-27

  Wang, Irnaten, and Mendelowitz found that agatoxin-IVA-sensitive voltage-dependent calcium channels contribute to nicotine-evoked presynaptic and postsynaptic responses in cardiac vagal neurons. Their pharmacological experiments distinguish this channel contribution from effects of L-type channel blockade and provide a framework for separating synaptic release from postsynaptic current in calcium-channel studies.

• Niclosamide Workflows for STAT3 Cancer Research

  2026-09-26

  Build a more interpretable Niclosamide experiment by pairing STAT3 Tyr-705 measurements with separate apoptosis and cell-cycle readouts. This practical guide also shows how a snail-control study informs experimental design—not Niclosamide’s anticancer mechanism—and where that comparison stops.

• Machine Learning Prediction of mRNA Vaccine LNPs

  2026-09-25

  Wang and colleagues combined a LightGBM model, mouse testing, and molecular dynamics to explore prediction of mRNA vaccine lipid nanoparticle performance. Their results support machine learning as a way to prioritize formulations for experimental testing, while also showing why predictions must be interpreted within the limits of the training data and assay endpoints.

8614 records 1/575 page Next 12345 下5页 Last page